Literature DB >> 3301638

The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer.

G A Pietersz, J Kanellos, M J Smyth, J Zalcberg, I F McKenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3301638     DOI： 10.1038/icb.1987.13

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  4 in total

Review 1.  Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.

Authors:  Daniel C Julien; Steven Behnke; Guankui Wang; Gordon K Murdoch; Rodney A Hill
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition.

Authors:  Y Lin; A Padmapriya; K M Morden; S D Jayasena
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

3.  Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.

Authors:  A Noguchi; T Takahashi; T Yamaguchi; K Kitamura; A Noguchi; H Tsurumi; K Takashina; H Maeda
Journal:  Jpn J Cancer Res       Date:  1992-03

Review 4.  Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer.

Authors:  Nasrul Wathoni; Lisa Efriani Puluhulawa; I Made Joni; Muchtaridi Muchtaridi; Ahmed Fouad Abdelwahab Mohammed; Khaled M Elamin; Tiana Milanda; Dolih Gozali
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.